Searchable abstracts of presentations at key conferences in endocrinology

ea0037gp.13.01 | Diabetes and obesity – Translational cardiovascular and obesity | ECE2015

Investigating chemerin/CMKLR1 signalling as a novel link between obesity and inflammatory bowel disease

Dranse Helen J , Rourke Jillian L , Stadnyk Andrew W , Sinal Christopher J

Background: Chemerin is a recently identified adipocyte-secreted signalling molecule (adipokine) that regulates adipocyte differentiation, metabolism, and inflammation through activation of the cognate receptor Chemokine-Like Receptor 1 (CMKLR1). Circulating chemerin levels are increased in obese patients as well as in patients with inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis. Increased white adipose tissue mass (WAT) and resultant chan...